Per Richard Torbjörn Hallberg
Director/Board Member presso DOVA PHARMACEUTICALS, INC.
Patrimonio netto: 698 450 $ in data 31/03/2024
Profilo
Per Richard Torbjörn Hallberg is currently a Director at Takeda Oy, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc., Swedish Orphan Biovitrum (Belgium) SARL, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB.
Previously, he worked as a Senior Associate at Advokatfirman Lindahl KB, Corporate Counsel at Ferring Pharmaceuticals, Inc., Corporate Counsel at Nycomed AB, and Vice President & General Counsel-Emerging Markets at Takeda AB.
He obtained a graduate degree from the University of Lund.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
02/10/2023 | 27 950 ( 0.01% ) | 698 450 $ | 31/03/2024 |
Posizioni attive di Per Richard Torbjörn Hallberg
Società | Posizione | Inizio |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | General Counsel | 01/01/2018 |
DOVA PHARMACEUTICALS, INC. | Director/Board Member | 12/11/2019 |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | Director/Board Member | 01/05/2016 |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Director/Board Member | - |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | Director/Board Member | 01/06/2021 |
Precedenti posizioni note di Per Richard Torbjörn Hallberg
Società | Posizione | Fine |
---|---|---|
Takeda AB | Director/Board Member | 01/01/2017 |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | General Counsel | 01/01/2010 |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | General Counsel | 01/01/2004 |
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 01/01/2001 |
Formazione di Per Richard Torbjörn Hallberg
University of Lund | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Aziende private | 8 |
---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Advokatfirman Lindahl KB operates a law firm. It specializes in commercial dispute resolution, mergers and acquisitions, intellectual property, and life sciences. The company was founded on January 1, 1990 and is headquartered in Stockholm, Sweden. | Commercial Services |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Health Technology |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Takeda AB | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Health Technology |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | Health Technology |
- Borsa valori
- Insiders
- Per Richard Torbjörn Hallberg